Andrew Schiermeier - EVP, Intellia Therapeutics, Inc

As of March 5, 2021


Andrew Schiermeier Net Worth

  • Net worth is estimated to be at least $1.41M
  • Owns at least 16,656 units of Intellia Therapeutics, Inc stock
  • Sold an estimated value of $76.92K in the last 3 years at Intellia Therapeutics, Inc

Andrew Schiermeier Compensation at Intellia Therapeutics, Inc in 2020

  • Earned a $455,400 salary and a $173 bonus
  • Received a total compensation of $1,718,528

Andrew Schiermeier Trading

  • Largest purchase of shares was 7,500 units , worth over $117.88K on March 12, 2019
  • Largest sale of shares was 1,377 units , worth over $76.92K on January 5, 2021
  • In total has made about 8 transactions over 3 years
  • Usually trades in March, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Andrew Schiermeier Mailing Address

  • Mailing address is C/o Intellia Therapeutics, Inc 40 Erie Street Ste 130 Cambridge MA 02139 MA

Intellia Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Stock Awards
Other Compensation
Total
John M. Leonard, M.D. 2020 $580,000 $319,000 $2,722,890 - $13,786 $3,635,676
John M. Leonard, M.D. 2019 $559,200 $307,560 - - $37,026 $903,786
John M. Leonard, M.D. 2018 $550,000 $302,500 $7,818,005 $1,011,713 $26,112 $9,708,330
Glenn G. Goddard 2020 $407,000 $146,520 $1,001,063 - $8,928 $1,563,511
Glenn G. Goddard 2019 $383,000 $153,200 - - $5,644 $541,844
Glenn G. Goddard 2018 $67,718 $51,652 $1,896,825 - $218 $2,016,413
David Lebwohl, M.D. 2020 $298,378 $228,000 $1,549,720 - $2,690 $2,078,788
Andrew D. Schiermeier, Ph.D. 2020 $455,400 $173,052 $1,081,148 - $8,928 $1,718,528
Andrew D. Schiermeier, Ph.D. 2019 $440,000 $167,200 $611,897 - $8,778 $1,227,875
Andrew D. Schiermeier, Ph.D. 2018 $408,934 $182,600 $2,028,554 $295,550 $9,668 $2,925,306
Laura Sepp-Lorenzino, Ph.D. 2020 $420,000 $184,800 $1,081,148 - $4,578 $1,690,526
Laura Sepp-Lorenzino, Ph.D. 2019 $239,487 $204,086 $1,318,695 - $221 $1,762,489
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1652130/000156459021021413/ntla-def14a_20210623.htm

Intellia Therapeutics, Inc Insider Trading

  • The most recent transaction was 2,400 units sold on November 9, 2021 by David Lebwohl worth over $318.53K
  • In the last 5 years, insiders at Intellia Therapeutics, Inc sold an estimated value of $305.57M and bought an estimated value of $44M
  • The most active traders are John Leonard, President and CEO,  Jose Rivera, EVP,  and Francois Jean Formela, Director
  • Insider trading is most common in May, with the busiest year in 2021

Intellia Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1